Brief: Protagenic Therapeutics To Effect 1-For-4 Reverse Stock Split
22/03/2023 18:17
March 22 (Reuters) - Protagenic Therapeutics Inc PTIX.O :
* PROTAGENIC THERAPEUTICS TO EFFECT 1-FOR-4 REVERSE STOCK SPLIT
* PROTAGENIC THERAPEUTICS INC - MEASURE TAKEN TO COMPLY WITH NASDAQ RULE 5550(A)(2)
REGARDING
MINIMUM BID PRICE
Source text - https://bit.ly/40peMmy
Further company coverage: PTIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln